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Glycosylation of integrins has been implicated in the modulation of their function. Characterisation of carbohydrate moieties of a3 and h1
subunits from non-metastatic (WM35) and metastatic (A375) human melanoma cell lines was carried out on peptide-N-glycosidase F-released
glycans using matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS). h1 integrin subunit from both cell lines displayed
tri- and tetraantennary oligosaccharides complex type glycans, but only in A375 cell line was the sialylated tetraantennary complex type glycan
(Hex7HexNAc6FucSia4) present. In contrast, only a3 subunit from metastatic cells possessed h1–6 branched structures. Our data indicate that
the h1 and a3 subunits expressed by the metastatic A375 cell line carry h1–6 branched structures, suggesting that these cancer-associated
glycan chains may modulate tumor cell adhesion by affecting the ligand binding properties of a3h1 integrin. In direct ligand binding assays,
a3h1 integrin from both cell lines binds strongly to fibronectin and to much lesser degree to placental laminin. No binding to collagen IV was
observed. Enzymatic removal of sialic acid residues from purified a3h1 integrin stimulates its adhesion to all examined ECM proteins. Our data
suggest that the glycosylation profile of a3h1 integrin in human melanoma cells correlates with the acquisition of invasive capacity during
melanoma progression.
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Cutaneous melanoma is one of the fastest-rising malig-
nancies in the last several decades. The multi-stage nature of
melanoma development provides an attractive model for
studying the transition from benign lesion to metastatic
cancer [1].
Many studies revealed that tumor cells often show a
decrease in cell–cell and cell–matrix adhesion correlated
with progression of malignancy. Integrins are the major
group of adhesion molecules responsible for mediating
cellular interactions with the extracellular matrix and appear
to have an important role in various aspects of cancer.
Essentially all types of cells show integrin-dependent adhe-0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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E-mail address: lita@zuk.iz.uj.edu.pl (A. Lityn´ska).sion based on binding of ECM components to various types
of integrin [2,3]. Most integrins which are a family of a/h-
heterodimers are able to bind different ligands with different
affinities. It seems clear that both a and h subunits extracel-
lular domains, which are heavily glycosylated, contribute to
the formation of the binding site. The affinity of integrins for
their ligands may vary depending on the cell type in which
they are expressed or as a result of conformational changes.
Glycosylation of integrins has been implicated in the mod-
ulation of their affinity.
Integrin a3h1 is widely distributed in almost all tissues,
and it has been suggested to be involved in tumor invasion
[4,5]. It has been reported to be a receptor for laminins [6,7],
fibronectin [8] and collagen [9]. However, recent works
suggested that it has a more restricted set of ligands [10].
Now a3h1 is considered primarily as a laminin-5 receptor
[11,12] and as a weak receptor for other ECM components
[13]. In contrast to integrin a6h4, another laminin-5 receptor,
integrin a3h1, is considered to play an active role in cell
spreading and motility on laminin-5 [14]. More recently, it
has been shown that a3h1 can form a stable and specific
association with the transmembrane-4 family member
CD151. This association provides a linkage with phospha-
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addition, a3h1 can pair with other tetraspanin proteins, which
in turn stimulates the production of MMP-2 [16]. The role of
these associations in melanoma has not been fully explored
but they may be important in tumor cell dissemination. a3h1
has been shown to be up-regulated in several melanoma cell
lines [4]. It is likely that a3h1 plays significant role in
melanoma development and tumor invasion, however, the
mechanism through which it modulates cell motility is not
yet understood. Furthermore, there is evidence suggesting
that a3h1 may also regulate a number of different cell
functions even without direct interaction with ECM, but
influencing cell behaviour via other integrins or via proteo-
litic ECM remodelling [17]. There is a growing amount of
evidence that integrin a3h1 transdominantly regulates integ-
rin a6h1 in mouse keratinocytes [18,19], or negatively
regulates integrin a2h1 in human breast carcinoma cell lines
[20].
Glycosylation is generally altered in tumor cells in
comparison with their normal counterparts. Post-translation-
al modulations of integrins include glycosylation of both a
and h subunits. Several roles for integrin glycosylation have
been suggested. The number and structure of N-linked
oligosaccharides is an important regulator of integrin func-
tion. This was particularly well-illustrated for h1 integrins
function in colon carcinoma [21], melanoma cell metastasis
[22–24], as well as human fibrosarcoma [25]. Multiple
reports have suggested that N-glycosylation of h1 integrins
is essential for optimal function [26–29].Fig. 1. The reaction of integrin a3 and h1 subunits with digoxigenin-labeled lecti
markers (HMW, Sigma). For immunodetection, 3 Ag GDP peptide-bound materiaThe N-linked glycosylation of human a3h1 has also been
analysed. In colon cancer, a3h1 integrin is a sialoglycopro-
tein containing h1–6 branched N-linked oligosaccharides
and short poly-N-acetyllactosamine structures. This is a
major carrier of oncodevelopmental and cancer-associated
carbohydrate epitopes [30]. Recently, we have shown by
matrix-assisted laser desorption ionization mass spectrome-
try (MALDI MS) the presence of complex type oligosac-
charides with a wide heterogeneity in both subunits of a3h1
from human ureter epithelium cells [31]. However, the exact
function of integrin a3h1 oligosaccharides remains to be
determined. In the present study, we found that integrin a3h1
from human melanoma cell lines with different metastatic
abilities differs in glycosylation profiles in a way that is
characteristic of invasive tumor cells. Moreover, in direct
adhesion assay, we provide evidence that enzymatic removal
of sialic acid residues from purified integrin a3h1 stimulates
its adhesion to fibronectin (FN) laminins: mouse and pla-
cental (LN) and collagen IV (Col). Our results suggest that
changes in integrin a3h1 glycosylation profiles may play an
important role in some steps of melanoma progression.2. Materials and methods
2.1. Chemicals
A Glycan Differentiation Kit containing the digoxigenin
(DIG)-labeled lectins and N-glycosidase F from Flavobac-ns: GNA, DSA SNA, MAA, AAA and PHA-L. Line S—molecular weight
l was used, and for lectin analysis—15 Ag.
Fig. 2. Western blotting analysis of a3h1 integrin treated with neuramini-
dase. GD6 peptide purified a3h1 integrin was digested with neuraminidase,
separated by SDS-PAGE and analysed by Western blotting with specific
antibodies for a3 (A) and h1 (B) subunit.
Fig. 3. Western blotting analysis of a3h1 integrin treated with PNGase and swainso
for 24 h, harvested in PBS and homogenized by sonification. GD6 peptide purifi
analysed by Western blotting with specific antibodies for a3 (A) and h1 (B) subu
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(Mannheim). Neuraminidase from Arthrobacter ureafaciens
was from Oxford GlycoSciences. PVDF membranes were
from Millipore. Collagen IV, fibronectin, laminin ESH
(mouse Engelbreth–Swarm–Holm), BSA solution, crystal
violet, proteinase inhibitor cocktail, fucose, Phaseolus vul-
garis agglutinin (PHA-L) were from Sigma Chemical Co.
All remaining chemicals were of analytical grade. Rabbit
polyclonal antisera against a3 subunit, mouse monoclonal
antisera against h1 subunit and human placental laminin
(hLN) were obtained from Chemicon.
2.2. Cell lines and culture conditions
Melanoma cell lines were kindly donated by Prof. A.
Mackiewicz from the Department of Cancer Immunology,
University School of Medical Sciences at Great Poland
Cancer Center, Poznan´, Poland. The WM35 cell line was
from primary tumor (established by Meenhard Herlyn, The
Wistar Institute, Philadelphia) and A375 (ATCC-CRT(L)-
1619) was from metastatic site.
The cell lines were cultured in medium RPMI 1640
(Sigma) containing 10% fetal bovine serum (FBS)
(GibcoBRLk) and antibiotics (penicillin—100 U/ml, strep-
tomycin—100 Ag/ml, Polfa Tarchomin, Poland). Cells were
grown in monolayers at 95% air/5% CO2 atmosphere at 37
jC in a humidified incubator. After reaching confluence, thenine. Cells were grown in the presence of swainsonine (10 Ag /1 ml RPMI)
ed a3h1 integrin was digested with PNGase, separated by SDS-PAGE and
nit.
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buffered saline. The cell pellets were homogenized in 50
mM Tris–HCl containing 15 mM NaCl, 1 mM MgCl2, 1
mM MnCl2, pH 7.4, and protease inhibitor cocktail (Sigma)
by sonification (five times, 5 s each) (Sonies, Vibra-Cell),
extracted for 1 h on ice with the same buffer containing
additionally 30 mM octyl-h-D-glucopyranoside and 3%
protamine sulfate. Finally, the cell extracts were clarified
by centrifugation at 35,000 g for 1 h (L7-65, Beckman).
2.3. Affinity chromatography
GD6 peptide (residues 3011–3032 of the globular
domain of the laminin A chain) [6] was synthesised atFig. 4. Positive-ion MALDI MS mass spectrum of N-glycans obtained by PNGase
cell line (B), a3 subunit from A375 cell line (C), h1 subunit from A375 cell linethe Faculty of Chemistry, University of Gdansk, Poland.
This peptide was coupled to activated CH-Sepharose
(Sigma) according to the manufacturer’s instruction (Phar-
macia Fine Chemicals AB). Isolation of a3h1 integrin was
performed as described in detail in Ref. [31]. Briefly,
about 5 mg of protein was loaded onto the column,
allowed to interact with the immobilised ligand overnight
at 4 jC and the bound material was eluted with 20 mM
EDTA in 50 mM Tris–HCl, pH 7.4 containing 30 mM
octyl-h-D-glucopyranoside. Fractions eluted with EDTA
were collected, dialysed against water and concentrated
to 0.5 ml by lyophilisation and then analysed by SDS-
PAGE under nonreducing conditions and probed with
specific antibodies.F digestion of: a3 subunit from WM35 cell line (A), h1 subunit from WM35
(D).
Fig. 4 (continued).
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For deglycosylation of the a3 and h1 subunits prior to
SDS-PAGE, 3 Ag of the material eluted from GD6-Sephar-
ose column was denatured by heating at 100 jC for 2 min in
5 Al of buffer (20 mM sodium phosphate, pH 7.5 containing
50 mM EDTA, 0.5% SDS, 5% mercaptoethanol). After
cooling, 1 Al of 10% non-ionic detergent (Nonidet P40),
followed by 0.35 U of peptide-N-glycanase F (PNGase F)
(Boehringer) were added and the solution was incubated
at 37 jC overnight. Material eluted from GD6-Sepharose
before or after deglycosylation was separated by 8% SDS-
PAGE in nonreducing condition according to Laemmli [32]
and transferred to a PVDF membrane, by electrophoretic
blotting [33] for 1 h at 100 V. The efficiency of protein
transfer was at least 95% as checked by staining the gel with
Coomassie Brilliant Blue R-250. Proteins immobilised on
PVDF membranes were stained with Ponceau S followed by
destaining in H2O. The blots were blocked in TBS/Tween
(0.02 M Tris–HCl, pH 7.6, containing 0.15 M NaCl and0.1% Tween 20), with 1% bovine serum albumin (BSA).
Afterwards, the membranes were sequentially incubated
with specific antibodies diluted in TBS/Tween with 1%
BSA (1:1000 for a3 and h1 subunits) for 2 and 18 h,
respectively. Mouse monoclonal antibodies to human integ-
rin subunit h1 (clone B3B11) from Chemicon, and rabbit
polyclonal antibodies to human a3 subunit (Chemicon) were
used. After triple wash with TBS/Tween, the blots were
incubated with alkaline phosphatase coupled secondary goat
anti-mouse or anti-rabbit Ig (Boehringer) (1:500 in TBS/
Tween with 1% BSA) for 1 h and the bands were localised
with 4-nitro blue tetrazolium chloride as a substrate.
2.5. Glycan chain analysis
Individual protein bands corresponding to the a3 and h1
subunits were excised from the PVDF membrane and
further glycan analysis was carried out according to the
method described by Ku¨ster et al. [34] as modified by Hoja-
æukowicz et al. [35], or was performed with the use of
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beck et al. [36] as described in detail earlier [37].
2.5.1. Protein alkylation
The excised PVDF membrane pieces were placed into
Eppendorf tubes and washed twice with 1 ml of 20 mM
NaHCO3, pH 7.0, for 15 min each. The wash was discarded
and dithiothreitol was added and the protein was reduced at
60 jC for 30 min. After cooling to room temperature, 20 Al of
100 mM iodoacetamide was added and the protein was
alkylated for 30 min at room temperature in the dark. The
reducing and alkylation reagents, as well as residual SDS
were then removed by incubation in 1:1 acetonitrile/fresh 20
mMNaHCO3, pH 7.0, for 60 h. Subsequently, the membrane
pieces were incubated in blocking solution (Boehringer).
2.5.2. In situ digestion
Prior to deglycosylation, PVDF membrane pieces were
washed three times with 20 mM NaHCO3, pH 7.0, for 15
min each. The washings were discarded and replaced with
0.5 U of PNGase F in 30 Al of 20 mM NaHCO3, pH 7.0, and
incubated at 37 jC for 12–16 h [38].
2.5.3. Sugar extraction
After deglycosylation, the incubation buffer was com-
pletely dried in a SpeedVacR Plus (Savant) and the residue
dissolved in 10 Al of ultrapure water (Milli-Q Plus, Millipore,
Bedford, CA, USA) and applied to microcolumn clean-up.
2.5.4. Microcolumn clean-up of sugars
Prior to MALDI MS, a microcolumn consisting of an
Eppendorf GELoader pipette tip packed with 5 Al each of
AG-3 (OH form, bottom) and AG-50 (H+ form, top) was
used. The column was washed with 100 Al of water and an
aliquot of the sugar sample was applied. Glycans were eluted
with 100 Al of water and dried in a SpeedVac.
2.5.5. MALDI mass spectrometry
MALDI mass spectra were recorded by using a Voyager
DE-PRO MALDI-TOF mass spectrometer (Applied Biosys-
tem) equipped with delayed extraction. The MALDI matri-
ces were prepared by dissolving 25 mg of 2,5-dihy-
droxybenzoic acid (DHB) in 1 Al of acetonitrile/0.2%
trifluoroacetic acid (70:30 v/v). Typically, 1 Al of the analyte
was then added. Mass calibration was performed with the
MH+ ion of insulin set atm/z 5734.6 and a known peptide ion
at m/z 1209.7. Raw data were analysed using the computer
software provided by the manufacturer, and are reported as
average masses.
2.6. Glycosidase digestions
a3h1 integrin GD6-Sepharose purified was diluted in
appropriate buffer and treated with 0.5 mU of PNGase F in
10 Al of 20 mM Na2HPO4, pH 7.5 or 10 mU of neuramin-
idase in 9 Al of 10 mM Tris–HCl, pH 6.5, containing 150mMNaCl at 37 jC for up to 18 h. As a control, an equivalent
of a3h1 integrin was incubated in the absence of appropriate
enzyme. Following incubation, the neuraminidase buffer
was adjusted to pH 7.4 by dilution with TBS/Mg buffer
(10 mM Tris–HCl, pH 7.4 containing 150 mM NaCl, 2 mM
MgCl2, 1 mMMnCl2) or TBS/EDTA (10 mM Tris–HCl, pH
7.4 containing 150 mM NaCl, 10 mM EDTA).
2.7. Modified ELISA integrin binding assay
Extracellular matrix proteins: hLN, ESH LN, Col, FN (10
Ag/ml) in TBS/Mg buffer were coated onto the microtiter
plate at 4 jC overnight. After being coated, the plate was
washed with the TBS/Mg buffer and non-specific binding
sites were blocked with a 1% solution of BSA in the TBS/Mg
buffer for 1 h in 37 jC. All the following steps were
performed at room temperature. Affinity purified integrin
a3h1 neuraminidase-treated, PNGase-treated or non-treated
were diluted in TBS/Mg buffer (3 Ag/well) and was added to
ligand-coated microtiter wells and allowed to adhere for 1
h at 37 jC. The wells were then washed three times with
TBS/Mg buffer or TBS/EDTA (non-specific binding). The
anti-a3 polyclonal antibody (Chemicon) was subsequently
added to the wells (1:1000 diluted in TBS/Mg buffer), and
the samples were incubated for additional 90 min at 37 jC.
After the wells were washed three times with the TBS/Mg
buffer, secondary goat anti-rabbit IgG antibody coupled to
alkaline phosphatase diluted 1:1000 in TBS/Mg buffer was
applied for 1 h. After three washings with TBS/Mg buffer,
ELISA was developed by adding pNpp (Sigma) and the
absorbance was measured at 405 nm after 18 h of incubation.
Values for non-specific binding, measured in the presence
of 10 mM EDTA were subtracted from total binding to
give values for the specific binding of integrin a3h1 to
immobilised ligands. Each value was determined in triplicate
and was repeated three times in independent experiments.
The significance of the differences between mean values
were computed using Dunkan’s new multiple range test.
*PV 0.05.
2.8. Other methods
Protein content was determined by the dye-binding meth-
od [39] using BSA as a standard. For protein sequencing,
affinity purified integrin was SDS-PAGE separation sub-
jected. The gel was stained with Coomassie Blue R-250,
destained and the proteins bands that migrated with an
apparent size of 168 and 130 kDa were cut out, dried and
then digested with tripsin and subjected to partial protein
sequence analysis by MS/MS.3. Results
In order to isolate the a3h1 integrin from human mela-
noma cell lines we used affinity chromatography on GD6
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tions of the resulting preparation revealed that the major
species migrating with apparent sizes of 168 kDa correspond
to both a3, and 140, 138 kDa correspond to h1 subunits from
WM35 and A375 cell lines, respectively. The identity of both
subunits were further confirmed by Western blotting with
specific anti-human antibodies and by peptide tripsin diges-
tion followed by MS/MS analysis.
3.1. Glycosylation pattern
The glycosylation patterns of isolated a3 and h1 subunits
were first examined with digoxigenin-labeled lectins (Fig. 1)
as previously described [40]. a3h1 oligosaccharides from
WM35 cells reacted with each used lectin except a3 subunit
with PHA-L. These results suggested the presence of high-
mannose type glycans as well as complex type with di-, tri-
and tetra antenna in case of h1 subunit. Part of the glycans
were also sialylated (reaction with Sambucus nigra aggluti-
nin (SNA) and Maackia amurensis agglutinin (MAA)) and
fucosylated (reaction with Aleuria aurantia agglutinin
(AAA)). In case of A375 cells, a3 subunit reacted with all
lectins except MAA, while h1 subunit reacted with all lectins
except Galanthus nivalis agglutinin (GNA). Comparison of
two cell lines indicated that in more invasive A375 cell line,
the glycosylation profile changed into structures moreTable 1
Hypothetical oligosaccharide structures observed in MALDI MS spectra of a3 an
WM35 A375
a3 Subunit h1 Subunit a3 Subunit
Number of
peak
Mass
(m/z)
Number of
peak
Mass
(m/z)
Number of
peak
1
1 1057.5
2 1569.5
3 1626.5
4 1666.6
2
1 1702.6
(K+, Na+)
2 1744.1
(Na+)
5 1745.5 3
3 1882.1 6 1880.6
4 1995.2
(Na+)
7 1995.2
(Na+)
4
5 2108.7
(K+, Na+)
8 2108.7
(K+, Na+)
5
6 2256.4
(K+, Na+)
9 2256.4
(K+, Na+)
6
2257.4 2257.4
10 2585.3
11 2786.2
12 2825.2
HexNAc—N-acetyl-D-glucosamine, Hex—D-mannose or D-galactose, Sia—sialicbranched (positive reaction of a3 subunit with PHA-L).
The presence or absence of sialic acid moieties as well as
branched oligosaccharides in a3 and h1 subunits was also
confirmed by neuraminidase digestion or cell culture in the
presence of swainsonine. Untreated and neuraminidase-trea-
ted purified a3h1 integrin were resolved by SDS-PAGE, then
Western blotting to detect the a3 and h1 subunits. As shown
in Fig. 2, neuraminidase-treated integrin demonstrated a
more rapid electrophoretic motility, consistent with the loss
of sialic acid. The differences in molecular weights were
8 and 10 kDa for a3, and 6 and 10 kDa for h1 subunits in
WM35 and A375 cell lines, respectively.
In the WM35 cell line, upon swainsonine treatment, only
h1 subunit showed decrease in size about 8 kDa suggesting
that only this subunit of integrin a3h1 possesses branched
oligosaccharides. On the opposite, in A375 line, a3 subunit
decreases in size about 11 kDa, while in h1, by about 18 kDa
showing that both are substrates for N-acetylglucosaminyl-
transferase (GlcNAc-TV) (Fig. 3).
Positive ion spectra were acquired by MALDI MS for the
total glycan pool released from the a3 (Fig. 4A,C), and h1
(Fig. 4B,D) subunits of WM35 and A375 cell lines, respec-
tively. Masses composition and the structures of glycans
released by PNGase F are listed in Table 1. The signals at
m/z 1744.1 and 1882.1 as well as 1719, 1883.4, 1880.6 likely
originate from high-mannose type glycans of the a3 and h1d h1 subunit from WM35 and A375 cell lines
Hypothetical
h1 Subunit
structure
Mass
(m/z)
Number of
peak
Mass
(m/z)
1477.4
(K+)
1 1477.4
(K+)
Hex5HexNAc3
Hex3HexNAc2Fuc
Hex4HexNAc3Sia
Hex4HexNAc4Fuc
Hex3HexNAc5Fuc
1687.4
(Na+)
Hex3HexNAc5Fuc
Hex5HexNAc4
1719.3 2 1720.2 Hex8HexNAc2
3 1883.4 Hex9HexNAc2
1995.4
(Na+)
4 1995.4
(Na+)
Hex4HexNAc5Sia
2109.5
(K+, Na+)
5 2109.5
(K+, Na+)
Hex5HexNAc6
2256.4
(K+, Na+)
6 2256.4
(K+, Na+)
Hex5HexNAc6Fuc
2257.4 2257.4 Hex4HexNAc6SiaS
Hex6HexNAc5Sia
Hex6HexNAc6Sia2
Hex8HexNAc6Sia
7 3724.2
(K+)
Hex7HexNAc6FucSia4
acid, Fuc–L-fucose, S—sulfate group.
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subunit and in both cell lines. Them/z value of 1476.4 as well
as 1477.4 in both a3 and h1 subunits from A375 correspond
to hybrid type glycans. In WM35 cells, a3 subunit had a
complex diantennary glycan as was shown by the presence of
signal at m/z 1702.6, while in A375 cells, the signal at m/z
1687.4 could correspond to triantennary complex type gly-
cans. The signals atm/z 1995.4, 2109.5 and 2254.6 of both h1
subunits and a3 from A375 line may be due to complex type
glycans with tri- or tetraantenna or alternatively to a complex
biantennary structures with a polylactosaminyl residues. The
m/z value of 1687.4 is only characteristic for subunit a3 from
A375 cell line and may be attributed to triantennary fucosy-
lated glycan. In fact, as it was shown by PHA-L reaction, only
a3 subunit fromA375 line was PHA-L-positive. For the same
reason, the structure Hex4HexNAc5Sia obtained for WM35
line a3 subunit could be attributed to HexNAch(1 –
4)Mana(1–3)Man complex triantennary type structure. Also
m/z value of 3724.2 was only observed in h1 subunit from
A375 cells and could correspond to sialylated tetrantennary
complex type glycan with fucose.Fig. 5. Ligand binding specificity of purified a3h1 integrin PNGase and
neuraminidase treated from WM35 (A) and A375 (B) cell lines. Ligands
(hLN—placental laminin, ESH LN—laminin ESH frommouse Engelbreth–
Swarm–Holm, Col—collagen IV, FN—fibronectin) were coated at 10 Al /ml
to the microtiter plate. Purified a3h1 integrin (3 Ag) was digested with
PNGase or neuraminidase and allowed to bind to the ligands in the presence
of either divalent cations (2 mMMgCl2 and 1 mMMnCl2) or 10 mM EDTA.
Integrin binding to the ligands was quantitated using amodified ELISA assay
as described in Materials and methods. The average of triplicate deter-
minations are shown: *PV 0.05. The significance of the differences between
mean values were computed using Dunkan’s new multiple range test.3.2. Ligand binding specificity of the soluble a3b1 integrin
With the isolated a3h1 integrin direct protein–protein
binding studies were possible. As indicated in Fig. 5A,
soluble a3h1 integrin from WM35 cell line bound strongly
to FN and to a much lesser degree to hLN. Very weak
adhesion to LN and ESH LN was also observed. Integrin
a3h1 from A375 line bound to hLN and rather weak to ESH
LN and FN (Fig. 5B). No binding to Col IV of a3h1 from
both cell lines were observed. As shown in Fig. 5, desialy-
lation of a3h1 integrin significantly enhanced attachment to
all examined ECM proteins in both cell lines. De-N-glyco-
sylation enhanced attachment but to a lesser extent than
desialylation, while in the cases of WM35 line to FN and
A375 line to hLN de-N-glycosylation were without effect. To
verify the degree of desialylation and deglycosylation, the
subunits were Western blotted to assay for changes in
electrophoretic mobility. As shown in Figs. 2 and 3, neur-
aminidase- and PNGase F-treated subunits had a more rapid
electrophoretic mobility than untreated subunits consisted
with the loss of sialic acid residues and the N-glycan
moieties.
ysica Acta 1643 (2003) 113–1234. Discussion
In this paper, we have shown that integrin a3h1 from
human melanoma cell lines with different metastatic abili-
ties differ in glycosylation profiles. In noncutaneous meta-
static A375 cell line, highly tumorogenic in nude mouse,
both subunits showed expression of carbohydrate epitopes
(Hex7HexNAc6FucSia4, Hex3HeNAc5Fuc), which may
contribute to cancer progression.
Metastasis of tumor cells is associated with the aberrant
glycosylation profile of cell surface glycoproteins [41–43],
in particular that of terminal sialylation [23] and h1–6
branched N-linked oligosaccharides with poly-N-acetyllac-
tosamine structures presence [30,44]. There is increasing
evidence that progression of cancer from a tumorogenic to
metastatic phenotype is directly associated with increased
level of h1–6 branching N-linked oligosaccharides as the
result of hyperactivity of GlcNAc-TV [42,45,46]. These
oligosaccharides which have the structure GlcNAc h(1–
6)Mana 1–6Man-R can be characterised by specific binding
to the lectin leucoagglutinin (PHA-L) [47]. Interestingly,
only a small number of glycoproteins are suitable substrates
for GlcNAc-TV activity. Preferred substrates are LAMP-1,
LAMP-2 [48], and CEA isolated from a number of colon
tumors [49–51]. Lastly, there is a growing amount of
evidence that the h1 integrin subunit could also be a substrate
for GlcNAc-TV [30,41,46,52].
In the present study, h1 integrin subunits from both non-
metastatic and metastatic cell lines displayed tri- and tet-
raantennary oligosaccharide complexes, but only in A375
cell line where sialylated tetraantennary complex type glycan
(Hex7HexNAc6FucSia4) was present. Additionally, the pres-
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cell lines was confirmed by reaction with PHA-L and by the
fact that from swainsonine-treated cells h1 subunit moved
slightly faster on SDS-PAGE. In contrast, a3 subunit only
from metastatic cell line A375 showed reaction with PHA-L
and moved faster on SDS-PAGE following swainsonine
treatment, indicating that it could also be a substrate for
GlcNAc-TV. a3 subunit from WM35 cell line did not react
with PHA-L, lectin-specific for h1–6 linked oligosacchar-
ides, and swainsonine did not influence its electrophoretic
mobility. Bearing in mind these results, it is more probable
that signals at m/z 2107.2 and 2254.6 correspond to N-
acetyllactosaminyl moieties than complex tetraantennary
structures. Also positive reaction of this subunit withDaturia
stramonium agglutinin (DSA)—lectin specific for short N-
acetyllactosamin residues—appears to support this observa-
tion. In contrast, in case of a3 subunit from A375 cell line, all
glycoforms at m/z 2107.2 and 2254.6 are possible. Our data
indicate that the a3 and h1 subunits expressed by the human
melanoma cell line (A375) carries h1–6 branched structures,
suggesting that these cancer-associated glycan chains may
modulate tumor cell adhesion by affecting the ligand binding
properties of a3h1 integrin.
A number of questions concerning the relationship be-
tween malignant phenotype and h1–6 branching remains to
be answered, but the growing line of evidence shows that
the large Asn-linked oligosaccharides may reduce cell
adhesion and facilitate cell migration and invasion. Expres-
sion of h1–6 GlcNAc-branched oligosaccharides on integ-
rins or other adhesion receptors may facilitate the turnover
of cell–cell and ECM contacts to accelerate cell motility
[42]. Studies on several adhesion-mediated glycoproteins
support this view [41,48]. EJ-ras-transformed NIH-3T3
fibroblasts acquired migratory phenotype accompanied by
overexpression of a6h1 integrin bearing oligosaccharides
recognised by PHA-L [41]. In human hepatocarcinoma
cells, increases of h1–6 GlcNAc branching by overexpres-
sion of GlcNAc-TV significantly affect the function of
integrins leading to increased cell migration and invasion
through matrigel [46].
Although the question of whether the addition of h1–6
branching on integrin a3h1 glycans can modulate its function
is not known, there is evidence suggesting that N-linked
carbohydrates can interfere with protein–protein interac-
tions. Various extracellular matrix proteins have been pro-
posed to be ligands for the a3h1 integrin but it was often
done on the basis of cell adhesion studies. The role of VLA-3
in adhesion to ECM proteins has been difficult to assess
since its specificity for ligands depends on the presence of
other integrins that may display a higher activity for the same
ligands [10,19]. Here with the purified a3h1 integrin, their
adhesion properties to LN, FN, and Col in direct binding
studies were possible. In order to understand the relationship
between carbohydrate structure and adhesion properties, we
have investigated the effect of desialylation and de-N-gly-
cosylation of a3h1 integrin.Interestingly, most of the suspected ligands showed very
weak or no binding to purified from human melanoma cell
lines a3h1 integrin. It did not recognise mouse laminin or
collagen IV and minimally recognised human laminin. Our
results are partly consistent with adhesion study demonstrat-
ing that recombinant soluble a3h1 integrin bound strongly to
laminin-5 and placental laminin, but did not bind to collagen
IV and fibronectin [53]. Also, Weitzman et al. [54] have
found that a3 transfected cell lines did not adhere to FN, LN
and Col and suggested that relatively weak adhesion to these
proteins may be suitable for migration of these cells. Our
results are consistent with cell adhesion studies which
previously demonstrated that a3h1 integrin is involved in
invasion and migration of melanoma cells, not in adhesion.
Antibodies to the a3 subunit did not inhibit adhesion of
melanoma cells to LN, FN or Col IV, in contrast, the same
antibodies were good inhibitors of migration of the cells,
suggesting a special role for a3h1 integrin in the migration
and invasion of melanoma cells [4]. In our study, a3h1
integrin did not adhere to Col IV despite a previous report
that a3h1 integrin from melanoma and breast cancer directly
bind to a1(IV) 531–543 peptide of Col IV [55]. However,
enzymatic removal of sialic acid restored adhesion of a3h1
integrin to Col IV and enhanced adhesion to LN and FN.
The presence of sialic acid on a glycoconjugate has two
important properties that make it likely to be involved in the
regulation of binding. Sialic acid is located only in a
terminal position on the glycan and it is negatively charged.
Because of their terminal localisation and negative charge,
sialic acids have the potential to inhibit interactions between
molecules and even cells. In N-linked glycoproteins, sialic
acids are attached to Gal with a2,6 and a2,3 linkages. In our
study, from lectin probing it was shown that h1 subunit form
both cell lines and a3 subunit from WM35 line has both
types of sialic acid linkage, while a3 subunit from A375 line
had only a2,6 linkage. Tumor-associated alteration in a2,6
sialylation of N-glycans have been described in a number of
studies. Lin et al. [56] have shown that cell surface a2,6
sialylation contributes to cell–cell and cell–ECM adhesion
in breast carcinoma cells. The cells carrying increased
amounts of sialic acid adhered preferentially to collagen
IV and showed reduced cell–cell adhesion and enhanced
invasion capacity. Accumulating evidence suggests that,
sialylation of cell surface receptors is inversely correlated
with cell adhesion to extracellular matrix [57], although this
has not been universally observed. Praetorius and Spring
[57] have shown by confocal epifluorescence microscopy
that fibronectin did not bind to sialylated h1 integrin in
MDCK cells. It was hypothesized that the negatively
charged sialic acid could play an important role in masking
h1 integrin, and that fibronectin binds only to desialylated
h1 integrin on MDCK cells. Sialic acids are closely associ-
ated with cell recognition phenomena [58,59]. They could
potentially inhibit intermolecular and intercellular interac-
tions by their negative charge. However, they could also act
as critical components of ligands recognised by a variety of
E. Pochec´ et al. / Biochimica et Biophysica Acta 1643 (2003) 113–123122proteins [58]. Nadanaka et al. [60] have found that in in-
tegrin a5h1, a major fibronectin receptor occurs a2–8 linked
oligosialic acid. After the loss of oligosialic acid, integrin
a5h1 failed to bind to fibronectin-conjugated Sepharose,
indicating that oligosialic acid on the a5 subunit plays
an important role in cell adhesion to fibronectin probably
by bringing the conformation into the high affinity form to
the ligand. In contrast Morgenthaler et al. [61] could not
observe altered adhesion of human colon carcinoma cells to
LN and FN after treatment with neuraminidase. Treatment
of breast carcinoma cells with neuraminidase reduces their
adhesion to collagen IV. Thus, sialic acid in particular a2–6
linked to components of the cell membrane promote cell
adhesion to Col IV but not to LN and FN [56]. In our study,
we have demonstrated that following neuraminidase treat-
ment, integrin a3h1 binding to FN, LN and Col significantly
increased. In agreement with the results presented here are
results of Pretzlaff et al. [62] and Semel et al. [63]. In both
cases, enzymatic removal of sialic acid residues from
purified integrin a5h1 [63] or h1 integrin on HL60 cells
[62] increases binding to FN.
Our current results may suggest the involvement of a3h1
integrin in the acquisition of invasive capacity during mel-
anoma cell progression. However, a number of questions
concerning the modification of cancer cell behaviour by
glycosylation remains to be answered.Acknowledgements
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